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Abstract
Objective To determine whether there is an association between use
of substances that contain caffeine and the risk of crash in long distance
commercial vehicle drivers.
Design Case-control study.
SettingNew SouthWales (NSW) andWestern Australia (WA), Australia.
Participants 530 long distance drivers of commercial vehicles who were
recently involved in a crash attended by police (cases) and 517 control
drivers who had not had a crash while driving a commercial vehicle in
the past 12 months.
Main outcome measure The likelihood of a crash associated with the
use of substances containing caffeine after adjustment for factors
including age, health disorders, sleep patterns, and symptoms of sleep
disorders as well as exposures such as kilometres driven, hours slept,
breaks taken, and night driving schedules.
Results Forty three percent of drivers reported consuming substances
containing caffeine, such as tea, coffee, caffeine tablets, or energy drinks
for the express purpose of staying awake. Only 3% reported using illegal
stimulants such as amphetamine (“speed”); 3,4
methylenedioxymethamphetamine (ecstasy); and cocaine. After
adjustment for potential confounders, drivers who consumed caffeinated
substances for this purpose had a 63% reduced likelihood of crashing
(odds ratio 0.37, 95% confidence interval 0.27 to 0.50) compared with
drivers who did not take caffeinated substances.
Conclusions Caffeinated substances are associated with a reduced
risk of crashing for long distance commercial motor vehicle drivers. While
comprehensive mandated strategies for fatigue management remain a
priority, the use of caffeinated substances could be a useful adjunct
strategy in the maintenance of alertness while driving.
Introduction
Long distance drivers of commercial motor vehicles routinely
experience monotonous and extended driving periods in a
sedentary position; this, combined with the disruption to
circadian rhythms linked to the common requirement of night
driving, has been associated with wake time drowsiness.1 2
Alertness is critical to safety for the driver and other road users
as lapses of vigilance in relation to the task of driving can
increase the likelihood of crashing.3 4 Many strategies are
available to long distance drivers to maintain their alertness,
and studies have identified positive benefits from the use of
stimulants such as caffeine.5 6We investigated the effects of use
of caffeinated substances on the likelihood of a crash among
long distance drivers of commercial motor vehicles.
Caffeine is a psychostimulant that works by suppressing the
innate adenosine mediated drive to sleep while activating
arousal7 8 and is one of the most commonly consumed stimulants
worldwide.9 It has been shown to increase alertness in shift
workers10 and improve the capacity for task performance.5When
used in excess, however, caffeine can also affect the quantity
and quality of sleep, as sleep latency is prolonged and slow
wave sleep is reduced.11 The effectiveness of caffeine for
enhancing alertness in the performance of monotonous tasks
has previously been shown in laboratory and driving simulator
settings.5 12 Some authors have raised concerns about the
methods used in these studies—namely, that the effects seen in
comparisons of caffeine and placebo groups are simply an
exaggerated response to caffeine withdrawal because of caffeine
deprivation before the test and not caused by the substance
alone.13 In contrast, a recent study used a field setting and found
that a combination of caffeine and naps improved performance
and alertness for night workers,14 and Mets and colleagues15 16
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have described both driving improvement and increased
alertness in a simulator setting while adjustment for average
daily caffeine consumption to prevent withdrawal effects after
administration of coffee.
A recent systematic review examined the influence of caffeine
in the prevention of injuries caused by impaired alertness in
shift workers. While the use of caffeine was recognised as an
effective strategy for improving alertness, the findings were
inconclusive in relation to any reduced likelihood of injury.10
Stimulant substances other than caffeine include nicotine and
illegal substances such as amphetamine drugs in their various
forms. Research regarding the use and influence of illegal
stimulants in long distance drivers is limited but does suggest
that their use is still occurring; and the self reported prevalence
of illegal stimulant use among Australian long distance drivers
has varied from 19% to 32%.17-19 Importantly, most drivers in
these studies attributed their use to the need to maintain alertness
while driving long distances.19 Mabbot and Harley18 suggested
that efforts to reduce the use of illegal stimulant substances in
these drivers would need to be introduced at the same time as
equally effective countermeasures to maintain alertness on the
road to prevent an increase in the incidence of crashes. None
of these studies simultaneously explored the use of legal
stimulant substances (such as caffeine) for the purpose of
maintaining alertness.
We explored the use of caffeinated substances among a large
population of long distance drivers of commercial vehicles and
investigated the effect of use of legal stimulants in relation to
the risk of crashing.
Methods
We conducted a case-control study between December 2008
andMay 2011 across the Australian states of New SouthWales
(population 7.3 million) and Western Australia (population 2.3
million).20 Participants were long distance drivers whose vehicle
mass was at least 12 tonnes tare weight (for example, B-doubles,
semi-trailers, road trains). Case drivers had to have crashed their
commercial vehicle while on a long distance trip (defined as at
least 200 km from the driver’s operating base). Potential case
participants were excluded if there was a fatality associated with
the crash, the driver of the commercial vehicle was seriously
injured (defined as being admitted to hospital for two weeks or
more or losing consciousness as a consequence of the crash),
or if they were driving a passenger coach or bus. Control drivers
also had to be on a long distance trip (at least 200 km from base)
at the time they were approached at the truck stop for interview.
Control drivers were deemed ineligible if they had been involved
in a crash attended by police in the previous 12 months or if
they were driving a passenger coach or bus. Sample size
calculations for this study are described elsewhere.21
Identification of case drivers
Reports of crashes involving commercial vehicles that were
attended by police were sent weekly to the study team from the
police crash database in each state. Drivers of the commercial
vehicle were then sent a letter of invitation to participate in the
study in which the driver was assured confidentiality should
they choose to take part. They were informed that their data
would be de-identified once they had completed both the
interview and the diagnostic sleep apnoea test overnight and no
participants would be identifiable in any reports or papers arising
from the study. A trained interviewer conducted the telephone
interview. Over the study period, 1751 case drivers were
identified and invited to participate in the study, of whom 895
were eligible. Of these, we recruited into the study 530 drivers
who had been involved in a crash attended by the police (59%).
Identification of control drivers
Control drivers were approached at one of 25 different truck
stops across NSW and WA. Interview locations were chosen
based on information from industry and road authorities
regarding major trucking routes for long distance drivers in each
state. Drivers of heavy vehicles were randomly approached
while they stopped for a meal break; 891 were deemed eligible
for inclusion in the study, of whom 517 consented and
participated in a face to face interview (58%). Interviews were
conducted across all days of the week, times of day, and months
of the year, and on 66 different interviewing occasions over the
study period. As for cases, all controls were assured
confidentiality (with anonymity after completion of the second
part of the study as described above) to minimise selection bias.
Measurement of risk factors
State based teams of research interviewers, all trained by the
study’s project manager, conducted a 40 minute interview with
all study participants. The interview included questions on
drivers’ characteristics such as demographics, anthropometry,
medical conditions, and drugs. We also obtained information
regarding health behaviours such as patterns of alcohol
consumption22 and use of legal and illegal substances to maintain
alertness; these questions related to consumption over the
previous month. Health related behaviours such as levels of
physical activity and sleep quantity, quality, and sufficiency
were self reported, and participants were asked the standardised
validated questions in the Epworth sleepiness scale23 to measure
wake time sleepiness and the multivariable apnoea prediction
index24 to ascertain symptoms of the sleep disorder, obstructive
sleep apnoea. All participants reported data related to
employment and vehicle as well as a detailed summary of
scheduling information outlining work hours, breaks, and rests
over the three days before the crash (for cases) and the interview
(for controls). We collected specific detail about the “index
trip”—that is, the trip in which the driver crashed for cases and
the last driving day before the interview for controls. Drivers
who crashed were generally interviewed within four weeks after
the crash, according to ethically approved notification timelines;
attention was paid to ensuring interviews were conducted as
soon as possible within this timeline to minimise recall bias.
To determine the consumption of caffeinated stimulant
substances such as tea, coffee, energy drinks, or caffeine tablets,
we asked drivers to specify what (if any) substances they
consumed for the purpose of staying awake while they were
driving during the previous month. Drivers were asked to
describe consumption patterns over that month, in quantity and
frequency. Amounts consumedwere described in an open ended
format and then coded based on guidelines developed by
Addicott and colleagues,25 such that a “cup of coffee” or a “can
of energy drink” contained 100 mg of caffeine and a cup of tea
or can of caffeinated soft drink contained 50 mg of caffeine.
Caffeine tablets purchased over the counter contain 100 mg per
tablet and were therefore coded as such. We combined the
amounts with the drivers reported frequencies and then
converted individual responses into three levels of consumption:
“low,” “moderate,” and “high.” Low caffeine users consumed
less than 200 mg a day, moderate caffeine users 200-400 mg a
day, and high caffeine users more than 400 mg a day.25 To
ascertain the use of illegal stimulants, we asked drivers to
indicate what (if any) illegal drugs they had used over the
previous month. The list contained commonly known stimulant
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substances such as “speed” (amphetamine), cocaine, and ecstasy
(3,4 methylenedioxymethamphetamine). If drivers said they
had used any of these substances they were then asked further
detail about the frequency and amount over the same period.
Statistical analyses
We used unconditional logistic regression to calculate the
likelihood of involvement in a crash in long distance drivers
who consumed stimulant substances containing caffeine (coffee,
tea, caffeinated soft drinks, caffeine tablets, energy drinks) as
well as other substances such as illegal stimulant drugs for the
purpose of staying awake while driving.We randomised a point
in time (for instance, hour of the day) of the detailed “index
trip” for controls to similarly represent the distribution of crashes
in case drivers and to allow statistical comparisons across the
index trip. We then used driving time and breaks taken on that
trip until the time of the crash or the randomised point in time
for controls to adjust risk estimates. We used logistic regression
to estimate the effects of stimulant use on the risk of crashing,
with adjustment for potential confounding factors. Independent
variables were selected if they were shown to have a relation
with the outcome variable in univariate analyses (P<0.2). We
also examined the effect modification by distance travelled for
the main exposure, as well as interactions between age and
various independent variables in the model. The final
multivariate unconditional logistic regression model was
adjusted for driving exposure (km travelled in the week before
the crash and the week before the interview for controls), night
driving (defined as the driver travelling more than half of the
trip between 11 pm and 5 am), and number of breaks taken
during the index trip. Adjustment was also made for the average
number of hours slept a night during the working week and over
the month before the crash/interview and a history of a previous
crash when driving a heavy vehicle that was attended by the
police in the previous five years, as well as the state in which
recruitment occurred.
All statistical analyses were performed with Stata version 11.0
(version 11.0 StataCorp, College Station, TX).
Results
Of the 1047 drivers recruited, almost all were men (99%,
n=1039). Case drivers were slightly younger than control drivers
(mean (SD) 44.2 years (10.8) v 46.1 years (9.9); P=0.004). Only
162 (15%) of all participants had a body mass index (BMI) in
the normal range; 391 (37%) were overweight and 494 (47%)
were obese. Significantly more control drivers were obese
(P=0.047).
Controls had significantly more driving experience than case
drivers (mean (SD) 19.9 (11.8) v 15.1 (11.9); P<0.001). Case
drivers were more likely to have had at least one crash in the
previous five years (excluding the current crash) (P=0.002).
Drivers in NSW were significantly more likely to stop for a
break at large truck stops or service stations with facilities for
truck drivers thanWAdrivers (585 (69%) v 92 (46%); P<0.001),
and WA drivers more likely to stop at a roadside rest area for
their breaks than NSW drivers (56 (28%) v 109 (12.8%),
respectively; P<0.001).
Table 1⇓ outlines the relevant characteristics of the drivers by
case and control status, with the unadjusted comparison. Table
1 also describes the drivers’ responses to questions regarding
consumption of caffeinated beverages and energy drinks for the
purpose of staying awake while driving over the past month
and use of illegal stimulants over the past month.
Behaviours significantly associated with crash risk at the
univariate level include the consumption of caffeinated
substances for the purpose of staying awake (odd ratio 0.34,
P<0.001), as well as hours of sleep (reported as “on average
over the past month” during work days, 1.29, P<0.001) (table
1⇓). We also examined other health behaviours such as exercise
frequency and alcohol consumption in univariate models.While
all drivers reported low rates of regular exercise compared with
national estimates26 there was no difference between cases and
controls (221 (41.7%) v 230 (44.5%), P=0.36) for frequency of
physical exercise. Heavy cigarette smoking was significantly
associated with crash risk univariately in the category of more
than one pack a day (odds ratio 0.49, P<0.001). According to
the categorisation model used for self reported caffeine
consumption (including tea, coffee, caffeinated soft drinks, and
caffeine tablets), high levels were consumed by 192 (37%) of
controls compared with 70 (13%) of case drivers. High
consumption of energy drinks was also reported by more
controls (71, 14%) than cases (34, 6%).
Drivers were also asked whether they had experienced any
difficulty staying awake while driving over the previous month
and then asked to quantify the frequency. There was a significant
difference in responses for this, with fewer case drivers than
controls reporting difficulty staying awake while driving (182
(34.3%) v 209 (40.5%), P=0.04). Drivers answering positively
to any degree for this question were then asked to indicate if
they would stop and have a nap if tired. Similar proportions of
case drivers (128 (70%) and controls (150, 72%) suggested that
they would pull over and nap if tired while driving (P=0.7).
Table 2⇓ presents the results of the multivariate regression
analysis exploring the association between the use of caffeinated
stimulant substances and the risk of crashing for long distance
drivers. Admission of the use of these substances for the purpose
of staying awake while driving was different between case
drivers and controls, with a significantly reduced risk of a crash
associated with consumption of caffeinated substances; this
association remained after adjustment for multiple confounders.
While consumption of illegal substances showed no relation
with the risk of crashing, the prevalence of drivers using such
stimulants was small. Heavy cigarette smoking was significant
in the univariate analysis, though this effect did not remain in
the multivariate model. A history of a previous crash was also
significant in univariate analyses, and this remained significant
after adjustment for multiple confounders, such that having had
a crash in the previous five years increased the risk of a crash
by 81%.
Discussion
In a large population of long distance commercial vehicle
drivers, the consumption of caffeinated substances for the
purpose of staying awake while driving was found to
significantly protect against crashing after adjustment for
multiple confounders. There was variation in reported caffeine
consumption between the two states examined—New South
Wales and Western Australia—and adjustment for this did not
significantly alter the estimates. Use of illegal stimulants was
not significantly associated with the risk of crash, though this
could be because of the low reported prevalence of such use.
These findings suggest that the consumption of legal stimulants
such as caffeine could be of value within the context of a
multi-faceted strategy tomanage fatigue to reduce the propensity
for crashes among long distance commercial drivers.
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Comparison with other studies
Our findings confirm those from previous research in which
consumption of caffeine and energy drinks was shown to help
in the maintenance of alertness for driving.5 27 Earlier research
used computerised laboratory tasks to measure of sustained
attention with and without caffeine consumption.28 Later studies
that measured levels of alertness with caffeine versus placebo
during prolonged driving in simulators were more comparable
with the monotonous task of long distance driving.29 While
previous studies predominantly compared a single dose of the
same amount of caffeine with a placebo,5 29 our study provides
new evidence for the influence of caffeinated substances,
reported as consumed “for the purpose of staying awake,” on
prospective outcomes of driving performance such as crashes.
Importantly, and confirming studies conducted in a simulated
environment, our study provides direct evidence in a real world
setting in which crashes can have severe and real life
consequences. Although we found a distinct difference in
consumption of caffeinated substance between case drivers and
controls, the validity of the levels of consumption (or
dose-response quantification) was subject to reporting bias and
therefore was not modelled other than as a binary variable for
which it was deemed robust.
Previous studies of stimulant use by drivers have focused on
illegal substances such as amphetamines, with higher self
reported consumption compared with that reported by drivers
in the present study.18 19 This could be a result of the roadside
drug testing and associated enforcement initiated in 2008 in
NSW and in 2007 in WA. A reduction in illegal stimulant use
among commercial vehicle drivers has also been observed in
the United States since the introduction of random roadside
drug testing.30 The lower reported use of illegal substances in
our study, however, could merely reflect a reticence by drivers
to admit their drug use because of the awareness of tighter
enforcement, despite being assured confidentiality for interview
responses.
Limitations
While commercial vehicle drivers quantified their “usual” daily
caffeine consumption over the past month “for the purposes of
staying awake,” they were not specifically questioned as to the
timing of consumption or whether they consumed caffeine for
other reasons nor were they provided any guide as to reporting
of quantities and frequencies. Future studies would benefit from
eliciting more information about the timing of consumption and
precise amounts consumed, as well as the alertness levels at the
time of and subsequent to consumption.
The exposure measures of interest were self reported and, as
such, have limitations. It is notable, however, that for the
quantification of habitual caffeine consumption and its effects,
almost all previous studies have used self report. Importantly,
the drivers in this study reported an average of 17 years’
experience in their profession; we therefore considered that
many of their behaviours were likely to be habitual. Despite the
considerable variability in the self reported quantities of
caffeinated beverages consumed as well as in consumption
patterns, previous research has reported a reasonable degree of
accuracy between self report and objective testing, albeit limited
at the higher consumption levels.25Taking this into account, we
minimised the potential for reporting bias associated with the
quantification of caffeine by only descriptively presenting the
dose measures and not including them in the parsimonious
model.
Given the need to undertake the study across two Australian
states, there is potential for state level factors to influence our
findings. For example, there are different legislative
requirements between the states regulating work practices of
long distance drivers, such as the fatiguemanagement guidelines
in NSW, which require all drivers to keep a work diary. This
record can be interrogated at mandated truck stops across the
state; in WA this does not apply. Such state specific factors
could have influenced driver behaviour as well as recall of their
behaviour, such as the number of breaks taken, hours driven,
and possibly other self reported behaviours. By adjusting for
these factors in the final model we have attempted to minimise
what effect these biases could have on the interpretation of the
study’s findings. We cannot, however, determine the precise
degree to which these factors might explain the counterintuitive
nature of some findings.
Conclusions and policy implications
The finding that the consumption of caffeinated substances can
significantly protect against crash risk for the long distance
commercial driver has important implications for the
improvement of fatigue management strategies for this and
similar populations—a strong focus both for government and
industry in Australia, particularly over the past decade. Recently
renewed fatigue management guidelines for all commercial
drivers25 imposed limits on the length of continuous driving
periods, the objective being to “provide sufficient rest breaks”
in a full day of driving. These guidelines also caution against
the use of illegal stimulants to manage fatigue, though the
consumption of caffeinated beverages is suggested as useful for
improving alertness for a short time. Napping during breaks
when tired is also strongly recommended; yet this is obviously
not enforceable. In our study only 70% of drivers reported
having stopped for a nap when tired, and, although we did not
probe in detail regarding impediments to nap taking, the numbers
suggest that it is not a strategy considered as favourable as others
for the management of fatigue. While it is clear that taking
breaks is a vital fatigue management strategy for long distance
drivers, it is possible that the different activities undertaken
during a break would contribute differently to a driver’s fatigue
or alertness level. The varying extent to which activities such
as taking a nap, drinking a cup of coffee, or going for a short
walk contribute to subsequent vigilance behind the wheel are
not well understood and are therefore recommended for further
study. In their recent systematic review of the role of caffeine
in injury prevention, Ker and colleagues similarly concluded
there is a need for a better understanding of the effects of
caffeine relative to other countermeasures.10
Accountability for the occupational health and safety of the long
distance driver is described in Australia as a “chain of
responsibility”25 that is shared by the regulator, employers and
operators, loading managers, suppliers, and the drivers
themselves. There are enforceable regulations that include
driving and rest periods; there are also various non-enforceable
but evidence based strategies that will help the driver to maintain
the alertness required to drive safely. Our findings suggest that
the consumption of caffeinated stimulant substances is
associated with a significantly reduced risk of involvement in
a crash for long distance drivers in Australia. While
comprehensive fatigue management strategies for these drivers
should consider the provision for adequate breaks and sufficient
sleep and the promotion of regular exercise, the use and
influence of caffeinated stimulants should be considered as an
effective adjunct strategy to maintain alertness while driving.
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What is already known on this topic
Long distance commercial vehicle drivers routinely experience monotonous and extended driving periods in a sedentary position;
combined with shift scheduling they are at considerable risk of daytime fatigue
Long distance drivers have been known to use illegal stimulants to counter fatigue
Caffeine is a widely consumed legal stimulant, known to enhance alertness and task performance in simulated driving; real world studies
with performance related outcomes such as crash are lacking in this population
What this study adds
Consumption of caffeinated drinks can reduce the risk of crashing among long distance commercial motor vehicle drivers by 63%
compared with drivers who do not report taking caffeinated stimulants for the purpose of staying awake while driving
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Tables
Table 1| Demographics, health characteristics, and consumption of stimulant substances in long distance commercial vehicle drivers who
were recently involved in crash (cases) and control drivers who had not crashed in previous 12 months, with odds ratio for crash risk.
Figures are numbers (percentage) of participants unless stated otherwise
P valueUnadjusted odds ratio (95% CI)Controls (n=517)Cases (n=530)
0.0020.97 (0.95 to 0.99)30.8 (5)29.7 (5.4)Mean (SD) BMI
0.521.02 (0.85 to 1.39)188 (36.4)203 (38.3)Overweight*
0.050.78 (0.61 to 0.99)261 (50.5)234 (44.2)Obese†
<0.0011.29 (1.17 to 1.42)6.76 (1.4)7.22 (1.3)Mean (SD) hours of sleep
<0.0010.48 (0.42 to 0.73)408 (78.9)357 (67.3)Regular consumption of alcohol
0.030.97 (0.94 to 0.99)6.5 (6.0)5.7 (4.3)Means (SD) No of standard drinks consumed per
occasion
0.361.1 (0.87 to 1.43)230 (44.5)221 (41.7)Regular exercise taken
0.431.03 (0.94 to 1.13)3.3 (2.1)3.4 (1.8)Mean (SD) days of exercise/week
0.0021.67 (1.21 to 2.29)75 (14.7)119 (22.5)Previous crash‡
<0.0010.99 (0.99 to 0.99)4384 (1701)3178 (1585)Mean (SD) km driven in past week
Uses substance to stay awake:
1227 (43.9)368 (69.4)No











0.060.47 (0.22 to 1.0320 (3.9)10 (1.9)Often/sometimes used illegal stimulant¶
*BMI >25-<30.
† BMI >30.
‡One or more crashes when driving long distance in commercial vehicle that was attended by police in past five years.
§Caffeine in tea, coffee, caffeinated soft drinks, and caffeine tablets.
¶Including speed, ecstasy, cocaine.
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Table 2| Associations between use of stimulant substances and crashes in long distance commercial vehicle drivers who were recently
involved in crash (cases) and control drivers who had not had crashed in previous 12 months. Figures are numbers (percentage) of
participants
Adjusted* OR (95% CI)Controls (n=517)Cases (n=530)
Uses caffeinated stimulant:
1.00227 (43.9)368 (69.4)No†
0.37 (0.27 to 0.50)290 (56.1)162 (30.6)Yes
Uses illegal stimulants‡:
1.00497 (96.1)520 (98.1)Never†
0.68 (0.27 to 1.67)20 (3.87)10 (1.89)Often/sometimes
1.81 (1.26 to 2.62)75 (14.5)119 (22.5)Previous crash§
*Adjusted for age, distance driven, hours of sleep, night driving, and breaks taken and state of crash/recruitment.
†Reference category.
‡Including speed, ecstasy, and cocaine.
§Police attended CMV driver crash, past five years, not including current crash for cases.
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